Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter and Nine-Months ended December 31, 2025 as published in "Business Standard" and "Makkal Kural" on February 13, 2026
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has submitted copies of newspaper advertisements publishing its unaudited financial results for the quarter and nine months ended December 31, 2025. The results were published in two newspapers — Business Standard (English) and Makkal Kural (Tamil) — on February 13, 2026. This is a routine regulatory compliance filing required under SEBI's Listing Obligations and Disclosure Requirements (LODR), where listed companies must publish their quarterly financial results in newspapers. The actual detailed financial numbers are not contained in this filing itself; only the newspaper clippings have been shared with the exchange for record.
This is a procedural compliance filing and is unlikely to move the stock on its own. Investors should look for the actual Q3 FY26 results (revenue, profit, margins) within the published advertisements or the exchange's earlier results filing to assess the company's performance.